ES2171704T3 - Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento. - Google Patents

Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento.

Info

Publication number
ES2171704T3
ES2171704T3 ES96927035T ES96927035T ES2171704T3 ES 2171704 T3 ES2171704 T3 ES 2171704T3 ES 96927035 T ES96927035 T ES 96927035T ES 96927035 T ES96927035 T ES 96927035T ES 2171704 T3 ES2171704 T3 ES 2171704T3
Authority
ES
Spain
Prior art keywords
peptides
growth hormone
somatostatine
cycles
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96927035T
Other languages
English (en)
Inventor
Romano Deghenghi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2171704T3 publication Critical patent/ES2171704T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBEN PEPTIDOS CICLICOS DE FORMULA GENERAL (I), EN LA CUAL LOS GRUPOS SON COMO SE DESCRIBE EN LA MEMORIA DESCRIPTIVA, QUE PRESENTAN ACTIVIDAD INHIBIDORA SOBRE LA HORMONA DEL CRECIMIENTO. LOS PEPTIDOS DE FORMULA (I) TAMBIEN PRESENTAN ACTIVIDAD ANTICANCEROSA.
ES96927035T 1995-07-28 1996-07-17 Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento. Expired - Lifetime ES2171704T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001670A IT1277391B1 (it) 1995-07-28 1995-07-28 Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita

Publications (1)

Publication Number Publication Date
ES2171704T3 true ES2171704T3 (es) 2002-09-16

Family

ID=11372091

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96927035T Expired - Lifetime ES2171704T3 (es) 1995-07-28 1996-07-17 Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento.

Country Status (14)

Country Link
US (1) US5962409A (es)
EP (1) EP0842193B1 (es)
JP (1) JPH11510147A (es)
KR (1) KR100321448B1 (es)
AT (1) ATE213742T1 (es)
AU (1) AU6700996A (es)
BR (1) BR9609801A (es)
CA (1) CA2227980A1 (es)
DE (1) DE69619530T2 (es)
DK (1) DK0842193T3 (es)
ES (1) ES2171704T3 (es)
IT (1) IT1277391B1 (es)
PT (1) PT842193E (es)
WO (1) WO1997005167A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579967B1 (en) 1999-12-14 2003-06-17 The Salk Institute For Biological Studies Receptor-selective somatostatin analogs
GB0018891D0 (en) 2000-08-01 2000-09-20 Novartis Ag Organic compounds
US7019109B2 (en) * 2001-03-16 2006-03-28 The Salk Institute For Bilogical Studies SSTR1-selective analogs
US20040121407A1 (en) * 2002-09-06 2004-06-24 Elixir Pharmaceuticals, Inc. Regulation of the growth hormone/IGF-1 axis
CN1317031C (zh) * 2005-09-14 2007-05-23 上海第二医科大学附属新华医院 增强实体肿瘤细胞化疗敏感性的高效混合制剂
NO20220050A1 (no) 2005-11-21 2008-08-12 Novartis Ag Neuroendokrin tumorbehandling
BR112014004936A2 (pt) * 2011-09-04 2017-04-04 Glytech Inc polipeptídeo glicosilado e composição de drogas contendo referido polipeptídeo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
WO1992021383A1 (en) * 1991-06-03 1992-12-10 Mallinckrodt Medical, Inc. Radiolabelled somatostatin derivatives, their preparation and use
EP0597875A4 (en) * 1991-06-06 1995-02-08 Somanetics Corp OPTICAL OXIMETER FOR BRAIN TISSUE.

Also Published As

Publication number Publication date
AU6700996A (en) 1997-02-26
KR100321448B1 (ko) 2002-07-31
WO1997005167A1 (en) 1997-02-13
ATE213742T1 (de) 2002-03-15
PT842193E (pt) 2002-06-28
IT1277391B1 (it) 1997-11-10
HK1008225A1 (en) 1999-05-07
ITMI951670A1 (it) 1997-01-28
JPH11510147A (ja) 1999-09-07
DE69619530D1 (de) 2002-04-04
US5962409A (en) 1999-10-05
KR19990035961A (ko) 1999-05-25
CA2227980A1 (en) 1997-02-13
DE69619530T2 (de) 2002-08-08
BR9609801A (pt) 1999-07-06
EP0842193A1 (en) 1998-05-20
ITMI951670A0 (it) 1995-07-28
EP0842193B1 (en) 2002-02-27
DK0842193T3 (da) 2002-04-29

Similar Documents

Publication Publication Date Title
ES2195970T3 (es) L-ribavirina y usos de la misma.
HN1996000017A (es) Isotiazolonas
UY24553A1 (es) Compuestos insecticidas de tipo 5- amino -4-etilsulfinil-pirazol
DK0851925T3 (da) Humane Væksthormonvarianter
DK0466913T3 (da) Tilslutningsadaptor til katetre
TR199900239T2 (es)
ES2186300T3 (es) Oligopeptidos con actividad fungicida.
ES2141559T3 (es) Derivados de 2-ciano-1-sulfonamidofenil-1,3-diona y su uso como herbicidas.
AR003466A1 (es) Compuestos 14-hidroxi-2-desoxoparahercuamida b
ES2151921T3 (es) Analogo de dolastatina.
NO974321D0 (no) Nodulisporsyrederivater
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
FI894257A0 (fi) Foerfarande foer framstaellning av ett optiskt aktivt system, i synnerhet att tillaempas pao ett fordons koerljus.
ES2171704T3 (es) Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento.
FI882514L (fi) Medel foer extrudering av ett plasthoelje pao en traod.
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
ES2029799T3 (es) Derivados de 2,5,6,7 tetranor-4,8-inter-m-fenilen pg12.
FI871691A0 (fi) Klockrenegeringsarrangemang tillaempligt speciellt pao ett informationstransmissionssystem som anvaender den tiddelade fleraotkomstprincipen i en transmissionsriktning.
IT8722167A0 (it) Struttura di valvola cardiaca artificiale ad elevato rendimento.
FI904348A0 (fi) Anordning foer paofoering av ett ytskikt pao ytan av ett i laengsriktningen roerligt foeremaol, i synnerhet medelst ett pulverformigt belaeggningsmaterial i kabelindustrin.
ES2052105T3 (es) Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.
ATE216254T1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
MX9204736A (es) Uretanos ciclicos utiles como agentes antiarritmicos y antifibrilatorios.
ES2083964T3 (es) Nuevos esteres de bis-arilfosfato antagonistas del factor activador de plaquetas.
ES2171331T3 (es) Uso como pesticida de, al menos, un acido del ciclo del acido citrico en combinacion con glicerina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 842193

Country of ref document: ES